| Feb 13, 2025 |
Feb 14, 2025 |
Axsome Therapeutics, Inc.
|
CFO |
Sell |
15.0
|
-15,000
|
-15.02%
|
✓
|
$2M |
| Nov 18, 2021 |
Nov 22, 2021 |
Axsome Therapeutics, Inc.
|
CFO |
Buy |
78.8
|
+955
|
2.31%
|
✗
|
$33.7K |
| Jun 29, 2020 |
Jun 30, 2020 |
Axsome Therapeutics, Inc.
|
CFO |
Buy |
82.5
|
+777
|
1.92%
|
✗
|
$59.5K |
| Sep 26, 2019 |
Sep 30, 2019 |
Axsome Therapeutics, Inc.
|
CFO |
Buy |
90.0
|
+2,180
|
5.69%
|
✗
|
$54.1K |
| Jun 11, 2019 |
Jun 12, 2019 |
Axsome Therapeutics, Inc.
|
CFO |
Buy |
91.3
|
+1,920
|
100.00%
|
✗
|
$39.9K |
| Mar 19, 2019 |
Mar 21, 2019 |
Axsome Therapeutics, Inc.
|
CFO |
Buy |
95.0
|
+5,400
|
17.42%
|
✗
|
$67.9K |
| Jun 19, 2018 |
Jun 20, 2018 |
Axsome Therapeutics, Inc.
|
CFO |
Buy |
95.0
|
+31,000
|
100.00%
|
✗
|
$96.1K |